Factor IX - Emisphere

Drug Profile

Factor IX - Emisphere

Latest Information Update: 09 May 2011

Price : $50

At a glance

  • Originator Emisphere Technologies
  • Class Antihaemorrhagics; Blood coagulation factors
  • Mechanism of Action Blood coagulation factor replacements; Factor X stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Haemophilia

Most Recent Events

  • 20 Feb 1997 New profile
  • 20 Feb 1997 Suspended-Unspecified Phase in Haemophilia in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top